Talimogene Laherparepvec and Panitumumab for the Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Skin

Clinical trial NCT04163952 · TERMINATED

Trial details

NCT number: NCT04163952
Sponsor: Rutgers, The State University of New Jersey
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced Skin Squamous Cell Carcinoma Metastatic Skin Squamous Cell Carcinoma Recurrent Skin Squamous Cell Carcinoma

Start date: 2020-01-31
Primary completion: 2025-03-28
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.